China Pharma Balance Sheet - Quarterly (NYSEMKT:CPHI)

Add to My Stocks
$0.33 $0 (0%) CPHI stock closing price Mar 19, 2018 (Closing)

A thorough fundamental analysis involves using data from China Pharma balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the China Pharma stock analysis, and provides insights into the firm's financial performance. A company releases its balance sheet every quarter along with its quarterly results. China Pharma balance sheet as at the end of 2017 Q3 indicates an asset turnover ratio of 0.17 and debt to equity ratio of 0.18. Also check China Pharma revenue and China Pharma operating cash flow for the same period.

View and download China Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Marketable Securities---------
Raw Materials10.87M10.85M10.79M11.56M12.1M12.18M12.32M14.69M15.73M
Work In Progress---------
Finished Goods1.83M1.67M1.39M1.53M2.73M3.12M3.66M3.38M3.9M
Notes Receivable---------
Other Current Assets2.55M2.24M2.24M2.23M2.87M2.81M2.83M2.87M9.31M
Total Current Assets
Property Plant & Equipment38.76M37.41M36.77M36.46M37.86M37.98M39.11M38.81M39.31M
Accumulated Depreciation14.61M13.33M12.35M11.5M11.52M10.77M10.28M9.42M8.86M
Net Property Plant & Equipment
Investment & Advances35.41M35.38M35.77M35.49M39.45M40.25M42.3M42.03M41.33M
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets---------
Total Assets
Notes Payable1.08M4.62M4.88M4.9M4.76M3.93M3.78M3.8M2.48M
Accounts Payable1.89M2.14M2.87M3.06M3.47M2.86M3.74M2.82M4.32M
Current Portion Long-Term Debt2.29M1.32M1.44M1.44M1.49M1.5M1.55M1.54M3.14M
Current Portion Capital Leases---------
Accrued Expenses---------
Income Taxes Payable---------
Other Current Liabilities4.5M4.3M4.41M4.66M4.16M3.92M3.99M3.66M3.7M
Total Current Liabilities
Deferred Taxes/Income-------1M-
Convertible Debt---------
Long-Term Debt6.87M8.85M8.57M8.64M8.99M10.23M10.54M10.78M9.44M
Non-Current Capital Leases---------
Other Long-Term Liabilities---------
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus23.59M23.59M23.59M23.59M23.59M23.59M23.59M23.59M23.59M
Retained Earnings19.3M21.5M23.79M24.75M28.18M29.93M32.38M33.94M46.61M
Treasury Stock---------
Other Liabilities14.08M12M10.99M10.51M13.11M13.39M15.54M15.06M16.56M
Shareholders Equity57.03M57.14M58.42M58.9M64.93M66.96M71.56M72.64M86.81M
Total Liabilities & Shareholders Equity74.99M77.12M78.14M78.52M87.4M91.97M97.03M97.22M112.68M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Mylan financial analysis

Apart from balance sheet items, an investor would do well to keep track of the China Pharma stock price by looking at China Pharma historical stock prices. One can compare PE with industry average by looking at the China Pharma PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the China Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. China Pharma had total assets of $74.99M.
  • Liabilities: This item on the balance sheet implies the firm's, in this case China Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for CPHI stock stand at $17.96M.

China Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio